Characterization of Apolipoprotein J-Alzheimer's Aβ Interaction

Matsubara, Etsuro; Frangione, Blas; Ghiso, Jorge

doi:10.1074/jbc.270.13.7563

Cited by 153

The DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.

Characterization of Apolipoprotein J-Alzheimer's Aβ Interaction

Matsubara, Etsuro, Frangione, Blas, Ghiso, Jorge·1995·Journal of Biological Chemistry

DOI 10.1074/jbc.270.13.7563

Open this paper in CoChat — free account

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1074/jbc.270.13.7563

Cites

13 of 13 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

ApoE and apoJ form stable complexes with Aβ in vitro.
“In vitro, apoE and apoJ form stable complexes with A␤ (11, 16 -20), alter the aggregation of various A␤ peptides (21)(22)(23), and affect A␤ neurotoxicity (24 -27).”
From Apolipoprotein E Receptors Mediate the Effects of β-Amyloid on Astrocyte Cultures (2000) · cites this paper as [19]
The Results describe an apoJ–Aβ1-40 complex formed in vitro, and the Abstract says that apoE isoforms could not dissociate it at physiologic concentrations. The paper also reports apoE binding to Aβ, but does not establish that apoE–Aβ complexes are themselves stable. (LLM, conf=0.84)
Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Amyloid β-peptide is produced by cultured cells during normal metabolism
Haass, C., Schlossmacher, M. G., Hung, A. Y., Vigo-Pelfrey, C., Mellon, A., Ostaszewski, B. L., Lieberburg, I., Koo, E. H., Schenk, D., Teplow, D. B., et al. (1992) · Nature · doi:10.1038/359322a0 · Cited by 1,921
Isolation and quantification of soluble Alzheimer's β-peptide from biological fluids
Seubert, P., Vigo-Pelfrey, C., Esch, F., Lee, M., Dovey, H., Davis, D., Sinha, S., Schiossmacher, M., Whaley, J., Swindlehurst, C., et al. (1992) · Nature · doi:10.1038/359325a0 · Cited by 1,731
Production of the Alzheimer Amyloid β Protein by Normal Proteolytic Processing
Shoji, M., Golde, T. E., Ghiso, J., Cheung, T. T., Estus, S., Shaffer, L. M., Cai, X.-D., McKay, D. M., Tintner, R., Frangione, B., et al. (1992) · Science · doi:10.1126/science.1439760 · Cited by 1,447
Self-citation
Assembly and aggregation properties of synthetic Alzheimer's A4/beta amyloid peptide analogs.
Burdick, D., Soreghan, B., Kwon, M., Kosmoski, J., Knauer, M., Henschen, A., Yates, J., Cotman, C., & Glabe, C. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)48529-8 · Cited by 1,014
Amyloid-associated proteins α1-antichymotrypsin and apolipoprotein E promote assembly of Alzheimer β-protein into filaments
Ma, J., Yee, A., Brewer, H. B., Das, S., & Potter, H. (1994) · Nature · doi:10.1038/372092a0 · Cited by 871
Isoform-specific binding of apolipoprotein E to beta-amyloid.
LaDu, M. J., Falduto, M. T., Manelli, A. M., Reardon, C. A., Getz, G. S., & Frail, D. E. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)31529-6 · Cited by 540
Immunoglobulins and complement factors in senile plaques: An immunoperoxidase study
Eikelenboom, P., & Stam, F. C. (1982) · Acta Neuropathologica · doi:10.1007/bf00685397 · Cited by 454
Amyloid-beta aggregation: selective inhibition of aggregation in mixtures of amyloid with different chain lengths
Snyder, S. W., Ladror, U. S., Wade, W. S., Wang, G. T., Barrett, L. W., Matayoshi, E. D., Huffaker, H. J., Krafft, G. A., & Holzman, T. F. (1994) · Biophysical Journal · doi:10.1016/s0006-3495(94)80591-0 · Cited by 381
Apolipoprotein J: structure and tissue distribution
De Silva, H. V., Harmony, J. A. K., Stuart, W. D., Gil, C. M., & Robbins, J. (1990) · Biochemistry · doi:10.1021/bi00474a025 · Cited by 353
Dynamics of gene expression for a hippocampal glycoprotein elevated in Alzheimer's disease and in response to experimental lesions in rat
May, P. C., Lampert-Etchells, M., Johnson, S. A., Poirier, J., Masters, J. N., & Finch, C. E. (1990) · Neuron · doi:10.1016/0896-6273(90)90342-d · Cited by 339
The cerebrospinal-fluid soluble form of Alzheimer's amyloid β is complexed to SP-40,40 (apolipoprotein J), an inhibitor of the complement membrane-attack complex
Ghiso, J., Matsubara, E., Koudinov, A., Choi-Miura, N. H., Tomita, M., Wisniewski, T., & Frangione, B. (1993) · Biochemical Journal · doi:10.1042/bj2930027 · Cited by 304
Self-citation
Distribution of clusterin in Alzheimer brain tissue
McGeer, P. L., Kawamata, T., & Walker, D. G. (1992) · Brain Research · doi:10.1016/0006-8993(92)90071-g · Cited by 212
SP‐40,40, a protein involved in the control of the complement pathway, possesses a unique array of disulphide bridges
Kirszbaum, L., Bozas, S. E., & Walker, I. D. (1992) · FEBS Letters · doi:10.1016/0014-5793(92)80330-j · Cited by 76

Flagged first, then by citations

Research works printed but not linked: 42

Wisniewski, 1994, Neurobiol. A., 15, 143, 10.1016/0197-4580(94)90105-8 · DOI
Wisniewski, 1994, Ann. Neurol., 35, 245, 10.1002/ana.410350223 · DOI
Wisniewski, 1993, Ann. Neurol., 34, 631, 10.1002/ana.410340422 · DOI
Abraham, 1988, Cell, 52, 487, 10.1016/0092-8674(88)90462-X · DOI
Coria, 1988, Lab. Invest., 58, 454
Snow, 1987, Lab. Invest., 57, 120
Choi-Miura, 1992, Acta Neuropath., 83, 260, 10.1007/BF00296787 · DOI · Paper page
Wisniewski, 1992, Neurosci. Lett., 135, 235, 10.1016/0304-3940(92)90444-C · DOI · Paper page
Ishii, 1984, Acta Neuropath., 63, 296, 10.1007/BF00687336 · DOI
Eikelenboom, 1994, Virc. Archiv., 424, 421, 10.1007/BF00190565 · DOI
Gallo, 1994, Am. J. Pathol., 145, 526
Pericak-Vance, 1991, Am. J. Hum. Genet., 48, 1034
Strittmatter, 1993, Proc. Natl. Acad. Sci. U. S. A., 90, 1977, 10.1073/pnas.90.5.1977 · DOI · Paper page
Wisniewski, 1993, Biochem. Biophys. Res. Commun., 192, 359, 10.1006/bbrc.1993.1423 · DOI · Paper page
Schwarzman, 1994, Proc. Natl. Acad. Sci. U. S. A., 91, 8368, 10.1073/pnas.91.18.8368 · DOI
Schägger, 1987, Anal. Biochem., 166, 368, 10.1016/0003-2697(87)90587-2 · DOI
Choi, 1990, J. Immunol. Methods, 131, 159, 10.1016/0022-1759(90)90186-Y · DOI
Bryan, 1977, Anal. Biochem., 78, 513, 10.1016/0003-2697(77)90111-7 · DOI
Kim, 1990, Neurosci. Res. Commun., 7, 113
Murphy, 1988, J. Clin. Invest., 81, 1858, 10.1172/JCI113531 · DOI
de Silva, 1990, J. Biol. Chem., 265, 13240, 10.1016/S0021-9258(19)38290-0 · DOI
Slawin, 1990, Biochem. Biophys. Res. Commun., 172, 160, 10.1016/S0006-291X(05)80187-1 · DOI
Tobe, 1991, Cytogenet. Cell Genet., 57, 193, 10.1159/000133144 · DOI
Purrello, 1991, Genomics, 10, 151, 10.1016/0888-7543(91)90495-Z · DOI
Kirszbaum, 1989, EMBO J., 8, 711, 10.1002/j.1460-2075.1989.tb03430.x · DOI
Collard, 1987, Biochemistry, 26, 3297, 10.1021/bi00386a008 · DOI
Sylvester, 1991, Biol. Reprod., 45, 195, 10.1095/biolreprod45.1.195 · DOI
O'Bryan, 1990, J. Clin. Invest., 85, 1477, 10.1172/JCI114594 · DOI
Hartmann, 1991, J. Biol. Chem., 266, 9924, 10.1016/S0021-9258(18)92907-8 · DOI
Palmer, 1990, J. Biol. Chem., 265, 6617, 10.1016/S0021-9258(19)39193-8 · DOI
Choi, 1989, Mol. Immunol., 26, 835, 10.1016/0161-5890(89)90139-9 · DOI
Garden, 1991, J. Neurobiol., 22, 590, 10.1002/neu.480220605 · DOI
Danik, 1991, Proc. Natl. Acad. Sci. U. S. A., 88, 8577, 10.1073/pnas.88.19.8577 · DOI
Day, 1990, Mol. Endocrinol., 4, 1995, 10.1210/mend-4-12-1995 · DOI
Zlokovic, 1994, Biochem. Biophys. Res. Commun., 205, 1431, 10.1006/bbrc.1994.2825 · DOI
Dugid, 1989, Proc. Natl. Acad. Sci. U. S. A., 86, 7260, 10.1073/pnas.86.18.7260 · DOI
Buttyan, 1989, Mol. Cell Biol., 9, 3473, 10.1128/MCB.9.8.3473 · DOI
May, 1989, J. Neurol. Sci., 16, 473, 10.1017/S0317167100029796 · DOI
Hilbich, 1991, J. Mol. Biol., 218, 149, 10.1016/0022-2836(91)90881-6 · DOI
Pitas, 1987, J. Biol. Chem., 262, 14352, 10.1016/S0021-9258(18)47945-8 · DOI · Paper page
Koudinov, 1994, Biochem. Biophys. Res. Commun., 205, 1164, 10.1006/bbrc.1994.2788 · DOI
Zlokovic, 1993, Biochem. Biophys. Res. Commun., 197, 1034, 10.1006/bbrc.1993.2582 · DOI · Paper page

Sorted by citations

Clearance of Alzheimer’s amyloid-β1-40 peptide from brain by LDL receptor–related protein-1 at the blood-brain barrier
Shibata, M., Yamada, S., Kumar, S. R., Calero, M., Bading, J., Frangione, B., Holtzman, D. M., Miller, C. A., Strickland, D. K., Ghiso, J., et al. (2000) · Journal of Clinical Investigation · doi:10.1172/jci10498 · Cited by 1,413
Self-citation
Alzheimer’s Disease Risk Genes and Mechanisms of Disease Pathogenesis
Karch, C. M., & Goate, A. M. (2015) · Biological Psychiatry · doi:10.1016/j.biopsych.2014.05.006 · Cited by 1,357
Plasma and Cerebrospinal Fluid Levels of Amyloid β Proteins 1-40 and 1-42 in Alzheimer Disease
Mehta, P. D., Pirttilä, T., Mehta, S. P., Sersen, E. A., Aisen, P. S., & Wisniewski, H. M. (2000) · Archives of Neurology · doi:10.1001/archneur.57.1.100 · Cited by 582
The Alzheimer's Aβ-peptide is deposited at sites of complement activation in pathologic deposits associated with aging and age-related macular degeneration
Johnson, L. V., Leitner, W. P., Rivest, A. J., Staples, M. K., Radeke, M. J., & Anderson, D. H. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.192203399 · Cited by 447
In Vivo Assessment of Brain Interstitial Fluid with Microdialysis Reveals Plaque-Associated Changes in Amyloid-β Metabolism and Half-Life
Cirrito, J. R., May, P. C., O'Dell, M. A., Taylor, J. W., Parsadanian, M., Cramer, J. W., Audia, J. E., Nissen, J. S., Bales, K. R., Paul, S. M., et al. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-26-08844.2003 · Cited by 394
Exercise benefits on Alzheimer’s disease: State-of-the-science
Valenzuela, P. L., Castillo-García, A., Morales, J. S., de la Villa, P., Hampel, H., Emanuele, E., Lista, S., & Lucia, A. (2020) · Ageing Research Reviews · doi:10.1016/j.arr.2020.101108 · Cited by 337
Expression of human apolipoprotein E reduces amyloid-β deposition in a mouse model of Alzheimer's disease
Holtzman, D. M., Bales, K. R., Wu, S., Bhat, P., Parsadanian, M., Fagan, A. M., Chang, L. K., Sun, Y., & Paul, S. M. (1999) · Journal of Clinical Investigation · doi:10.1172/jci6179 · Cited by 349
Lipidation of apolipoprotein E influences its isoform-specific interaction with Alzheimer's amyloid β peptides
TOKUDA, T., CALERO, M., MATSUBARA, E., VIDAL, R., KUMAR, A., PERMANNE, B., ZLOKOVIC, B., SMITH, J. D., LADU, M. J., ROSTAGNO, A., et al. (2000) · Biochemical Journal · doi:10.1042/bj3480359 · Cited by 272
Self-citation
Amyloid-β Peptides Interact with Plasma Proteins and Erythrocytes: Implications for Their Quantitation in Plasma
Kuo, Y.-M., Kokjohn, T. A., Kalback, W., Luehrs, D., Galasko, D. R., Chevallier, N., Koo, E. H., Emmerling, M. R., & Roher, A. E. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.2222 · Cited by 230
Unique Lipoproteins Secreted by Primary Astrocytes From Wild Type, apoE (−/−), and Human apoE Transgenic Mice
Fagan, A. M., Holtzman, D. M., Munson, G., Mathur, T., Schneider, D., Chang, L. K., Getz, G. S., Reardon, C. A., Lukens, J., Shah, J. A., et al. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.42.30001 · Cited by 222
Systemic Catabolism of Alzheimer's Aβ40 and Aβ42
Ghiso, J., Shayo, M., Calero, M., Ng, D., Tomidokoro, Y., Gandy, S., Rostagno, A., & Frangione, B. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m407668200 · Cited by 209
Self-citation
NEBULA is a fast negative binomial mixed model for differential or co-expression analysis of large-scale multi-subject single-cell data
He, L., Davila-Velderrain, J., Sumida, T. S., Hafler, D. A., Kellis, M., & Kulminski, A. M. (2021) · Communications Biology · doi:10.1038/s42003-021-02146-6 · Cited by 181
Purification and characterization of astrocyte-secreted apolipoprotein E and J-containing lipoproteins from wild-type and human apoE transgenic mice
DeMattos, R. B., Brendza, R. P., Heuser, J. E., Kierson, M., Cirrito, J. R., Fryer, J., Sullivan, P. M., Fagan, A. M., Han, X., & Holtzman, D. M. (2001) · Neurochemistry International · doi:10.1016/s0197-0186(01)00049-3 · Cited by 180
A Synthetic Peptide Blocking the Apolipoprotein E/β-Amyloid Binding Mitigates β-Amyloid Toxicity and Fibril Formation in Vitro and Reduces β-Amyloid Plaques in Transgenic Mice
Sadowski, M., Pankiewicz, J., Scholtzova, H., Ripellino, J. A., Li, Y., Schmidt, S. D., Mathews, P. M., Fryer, J. D., Holtzman, D. M., Sigurdsson, E. M., et al. (2004) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63355-x · Cited by 154
Disease modifying therapy for AD?1
Golde, T. E. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.04211.x · Cited by 117
Apolipoprotein E Receptors Mediate the Effects of β-Amyloid on Astrocyte Cultures
LaDu, M. J., Shah, J. A., Reardon, C. A., Getz, G. S., Bu, G., Hu, J., Guo, L., & Van Eldik, L. J. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m000602200 · Cited by 103
Functional and structural properties of lipid-associated apolipoprotein J (clusterin)
CALERO, M., TOKUDA, T., ROSTAGNO, A., KUMAR, A., ZLOKOVIC, B., FRANGIONE, B., & GHISO, J. (1999) · Biochemical Journal · doi:10.1042/bj3440375 · Cited by 98
Self-citation
Apolipoprotein E and Alzheimer's disease: the protective effects of ApoE2 and E3
Rebeck, G. W., Kindy, M., & LaDu, M. J. (2002) · Journal of Alzheimer's Disease · doi:10.3233/jad-2002-4304 · Cited by 89
Familial Danish Dementia
Tomidokoro, Y., Lashley, T., Rostagno, A., Neubert, T. A., Bojsen-Møller, M., Braendgaard, H., Plant, G., Holton, J., Frangione, B., Révész, T., et al. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m504038200 · Cited by 68
Self-citation
Amyloid β-interacting partners in Alzheimer's disease: From accomplices to possible therapeutic targets
Han, S.-H., Park, J.-C., & Mook-Jung, I. (2016) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2015.12.004 · Cited by 67
Modulation of Amyloid-β1–40 Transport by ApoA1 and ApoJ Across an in vitro Model of the Blood-Brain Barrier
Merino-Zamorano, C., Fernández-de Retana, S., Montañola, A., Batlle, A., Saint-Pol, J., Mysiorek, C., Gosselet, F., Montaner, J., & Hernández-Guillamon, M. (2016) · Journal of Alzheimer's Disease · doi:10.3233/jad-150976 · Cited by 63
Apolipoprotein J (clusterin) activates rodent microglia in vivo and in vitro
Xie, Z., Harris‐White, M. E., Wals, P. A., Frautschy, S. A., Finch, C. E., & Morgan, T. E. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03065.x · Cited by 53
The absence of myelin basic protein promotes neuroinflammation and reduces amyloid β-protein accumulation in Tg-5xFAD mice
Ou-Yang, M.-H., & Van Nostrand, W. E. (2013) · Journal of Neuroinflammation · doi:10.1186/1742-2094-10-134 · Cited by 30
High-density lipoprotein-related cholesterol metabolism in Alzheimer's disease
Pedrini, S., Chatterjee, P., Hone, E., & Martins, R. N. (2021) · Journal of Neurochemistry · doi:10.1111/jnc.15170 · Cited by 22

Authors: Matsubara, E., Frangione, B., & Ghiso, J.
Venue: Journal of Biological Chemistry
Publisher: Elsevier BV
Published: 1995-03
Volume: 270
Issue: 13
Pages: 7563-7567
ISSN: 0021-9258
DOI: 10.1074/jbc.270.13.7563
Cited by: 153
References: 13
Language: en
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
creativecommons.org/licenses/by/4.0/ (vor, 9368 d)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Characterization of Apolipoprotein J-Alzheimer's Aβ Interaction

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Metadata

Record

About these checks